DPharm 2020 will provide a wide choice of tracks addressing virtual/flexible trials, digital applications, real world data, big data management, AI, master protocols, EHR, eSource operations, patient-centric strategies, new collaborations, business models and a diverse range of technologies. DPharm underscores the promise and challenge of innovation in advancing drug development.
We hope you can join Eli Alford, Elligo’s chief operating officer, during Track 3: Innovative Patient Solutions, for his presentation: How an Innovative Model Delivering Clinical Research Addresses Patient-Centric Rights and Increases Trial Participation on September 22 at 11:45 a.m. EDT.
In this session, learn how Elligo’s innovative model of delivering clinical trials within clinical research can address patient-centric rights to help increase participation and improve the patient experience by:
- Enabling patients to participate in research with their primary physician: research as a care option
- Expanding patient access by navigating across the spectrum of clinical operations models
- Offering data collection flexibility to meet patients at the right point of care